Literature DB >> 14551066

Directly observed treatment for tuberculosis.

Paul Garner, Jimmy Volmink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14551066      PMCID： PMC214007          DOI： 10.1136/bmj.327.7419.823

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Evolution of WHO policies for tuberculosis control, 1948-2001.

Authors:  M C Raviglione; A Pio
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

2.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

3.  Directly observed therapy and treatment adherence.

Authors:  J Volmink; P Matchaba; P Garner
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

4.  Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment.

Authors:  M A Khan; J D Walley; S N Witter; A Imran; N Safdar
Journal:  Health Policy Plan       Date:  2002-06       Impact factor: 3.344

Review 5.  Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.

Authors:  Martien W Borgdorff; Katherine Floyd; Jaap F Broekmans
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

Review 6.  Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel.

Authors:  C P Chaulk; V A Kazandjian
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

Review 7.  Directly observed therapy for treating tuberculosis.

Authors:  J Volmink; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 8.  Tuberculosis control: past 10 years and future progress.

Authors:  Thomas R Frieden; Cynthia R Driver
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131
  8 in total
  6 in total

1.  Depression comorbidity among patients with tuberculosis in a university teaching hospital outpatient clinic in Nigeria.

Authors:  Baba A Issa; Abdullah D Yussuf; Suleiman I Kuranga
Journal:  Ment Health Fam Med       Date:  2009-09

2.  Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.

Authors:  Shashikant Srivastava; Jotam G Pasipanodya; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  J Infect Dis       Date:  2011-10-21       Impact factor: 5.226

3.  Negotiating "The Social" and Managing Tuberculosis in Georgia.

Authors:  Erin Koch
Journal:  J Bioeth Inq       Date:  2016-01-06       Impact factor: 1.352

4.  Acceptable care? Illness constructions, healthworlds, and accessible chronic treatment in South Africa.

Authors:  Jana Fried; Bronwyn Harris; John Eyles; Mosa Moshabela
Journal:  Qual Health Res       Date:  2015-05

5.  An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes.

Authors:  Brian McKay; Maria Castellanos; Mark Ebell; Christopher C Whalen; Andreas Handel
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

6.  Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives.

Authors:  Geetika Verma; Ross E G Upshur; Elizabeth Rea; Solomon R Benatar
Journal:  BMC Med Ethics       Date:  2004-03-12       Impact factor: 2.652
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.